Amornchit S. Srikureja

Internal Medicine

2021 Santa Monica Boulevard
Suite 540E
Santa Monica, CA 90404

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

SAINT: A Phase I/Expanded Phase II Study Using Safe Amounts of Ipilimumab, Nivolumab and Trabectedin as First-Line Treatment of Advanced Soft Tissue Sarcoma.

SAINT: A Phase I/Expanded Phase II Study Using Safe Amounts of Ipilimumab, Nivolumab and Trabectedin as First-Line Treatment of Advanced Soft Tissue Sarcoma.

Journal: Cancers

Published: January 04, 2023

Showing 1-1 of 1

Last Updated: 09/26/2026